Applications Published 8 August 2001

Published: 30-Apr-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • A method for reducing amino acid biosynthesis inhibiting effects of a sulphonyl-urea based compound
    Novozymes 1121017*

  • Pharmaceutical compsn with gastric residence and controlled release
    Sanofi-Synthelabo 1121099*

  • Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
    Adir et Compagnie 1121100*

  • Aerosol ointment compsns and method of manufacture
    OMS Holdings 1121101*

  • Liposome-entrapped topoisomerase inhibitors
    Alza Corp 1121102*

  • Orally disintegrabe tablets
    Takeda Chemical Industries 1121103*

  • New sustained release oral formulations
    Novartis 1121104*

  • Propofol-based anaesthetic and method of making same
    Phoenix Scientific 1121105*

  • Treatment of dyspepsia
    Astacarotene 1121106*

  • Sertaline oral concentrate
    Pfizer 1121107*

  • Novel therapeutic use of compounds with beta-3-agonist activity
    Sanofi-Synethelabo 1121108*

  • Opioid analgesic
    Euroceltique 1121109*

  • Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
    Children's Hospital Research Foundation 1121110*

  • Compounds for the treatment of weight loss
    Imperial College Innovations 1121111*

  • Storable active substance concentrate with formenterol
    Boehringer Ingelheim 1121112*

  • Methods for regulating bone formation
    Merck 1121113*

  • Method for the treatment of mania and bipolar disorders
    Warner-Lambert 1121114*

  • PUFA supplements
    DSM 1121115*

  • Sustained release pharmaceutical compsn and method of release pharmauceutically active agents
    Novartis 1121116*

  • Oxaliplatinum preparation packaging
    Debiopharm 1121117*

  • Formamides as therpeutic agents
    Glaxo Group 1121118*

  • A new compsn
    AstraZeneca 1121119*

  • Use of ophthalmic compsn comprising vitamin A and vitamin E
    Novartis 1121120*

  • Methods for inhibiting complications
    University of South Carolina 1121121*

  • Treatment of depression
    H Lundbeck 1121122*

  • Formulations of fexofenadine
    West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1121123*

  • Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine
    Merck Sharp & Dohme 1121124*

  • Pharmaceutical formulation for use in estrogen deprivation syndrome
    Eli Lilly 1121125*

  • Method for treating schizophrenia and means used in said method
    LTS Lohmann Therapie-Systeme 1121126*

  • Oral pharmaceutical compsns containing buprenorphin
    Farmaceutici Formenti 1121127*

  • A method of modulating ion channel functional activity
    The Australian National University 1121128*

  • Method for treating diabetes employing an AP2 inhibitor and combination
    Bristol-Myers Squibb 1121129*

  • Zinc finger-reactive antimicrobial compounds
    University of Massachusetts 1121130*

  • Atypical antipsychotic in combination with acetylcholinesterase inhibitor for improving cognition
    Janssen Pharmaceutica 1121131*

  • Method and compsn for increasing bone mass
    The Board of Trustees of the University of Arkansas 1121132*

  • Methods for stimulating bone formation
    Merck 1121133*

  • Derivatives of erythromycin, clarithromycin, roxithromyin or azithromycin, with antibiotic and mucolytic activity
    Lauteral 1121134*

  • Compsns of beta-glycans and specific IGIV
    NABI 1121135*

  • Methods of administering adenoviral vectors
    Genvec 1121136*

  • Method for killing tumour cells and tumour associated endothelial cells using adenoviral mutants
    Onyx Pharmaceutical 1121137*

  • Compsns for the treatment of atherosclerosis and related conditions
    Dalidar Pharma Israel 1121138*

  • Natural formulation for the treatment of depression, containing St John's Wort and derivatives of dihydro- and tetrahydrofolic acid
    Merck 1121139*

  • Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
    The Regents of the University of California 1121140*

  • Angiogenically effective unit dose of FGF and method of administering
    Chiron 1121141*

  • Stable concentrated insulin preparations for pulmonary delivery
    Novo Nordisk 1121144*

  • Utilisation of proteolytic enzymes to influence hyperactive T cells
    Mucos 1121146*

  • Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
    Duke University 1121147*

  • Immunotimulant emulsion
    Aventis Pasteur 1121148*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now